Glucose monitoring device developer Movano sets terms for $36 million IPO
03/10/21
~March 10, 2021
"...Movano, which is developing a wearable device that measures glucose, blood pressure, and heart rate, announced terms for its IPO on Wednesday.
https://movano.com/
Not sure if it has FDA, CE approvals, or any revenue.
Dyor
~
US IPO Weekly Recap:
Biotechs flood the IPO market in a 14 IPO week
02/05/21
"....27 blank check companies raised $9.2 billion this past week.
The group was led by Starwood Capital founder Barry Sternlicht’s third SPAC Jaws Mustang Acquisition (JWSM.U), which raised $900 million to acquire a business in North America and/or Europe.~
41 IPOs During the Week of February 1st, 2021 Issuer
BusinessDeal
SizeMarket Cap
at IPOPrice vs.
MidpointFirst Day
ReturnReturn
at 02/05Vor Biopharma (VOR) $177M $711M 6% +108% +108% Preclinical biotech developing cell therapies for hematological diseases. Immunocore (IMCR) $258M $1,121M 8% +66% +66% Phase 3 biotech developing T cell therapies for cancer and other diseases. Bolt Biotherapeutics (BOLT) $230M $757M 18% +61% +61% Phase 1/2 biotech developing targeted therapies for solid tumors. Sana Biotechnology (SANA) $588M $4,928M 16% +40% +56% Preclinical biotech developing engineered cell therapies for multiple indications. Lucira Health (LHDX) $153M $705M 6% +47% +47% Developing single-use test kits for COVID-19 and other infectious diseases. Pharvaris (PHVS) $165M $668M 11% +45% +45% Dutch Phase 1 biotech developing oral small molecule therapies for rare diseases. ON24 (ONTF) $428M $2,770M 5% +42% +38% Provides a B2B customer engagement platform supporting webinars and analytics. TELUS International (TIXT) $925M $6,638M 4% +22% +26% Provides customer service outsourcing and digital IT services. Sensei Biotherapeutics (SNSE) $133M $591M 12% -1% +18% Phase 2 biotech developing bacteriophage-based therapies for cancer. Decarb. Plus Acq. II (DCRNU) $350M $428M 0% +13% +15% Fourth blank check company formed by Riverstone targeting businesses advancing global decarbonization. Sustainable Dev. Acq. I (SDACU) $275M $344M 0% +12% +12% Blank check public benefit corporation formed by RRG and Capricorn Investment Group. Atotech (ATC) $498M $3,345M -17% +13% +12% Carlyle-backed specialty chemicals company carved out of Total. Fifth Wall Acquisition I (FWAA) $300M $375M 0% +11% +11% Blank check company targeting a real estate technology business. Novus Capital Corp II (NXU.U) $250M $313M 0% +10% +10% Blank check company targeting businesses enabling smart technology evolution. RMG Acquisition III (RMGCU) $420M $525M 0% +9% +9% Third blank check company formed by Riverside's James Carpenter and former Carlyle executive Robert Mancini. G Squared Ascend I (GSQD.U) $300M $375M 0% +9% +9% Blank check company formed by G Squared targeting the tech sector. Terns Pharmaceuticals (TERN) $128M $430M 6% +8% +8% Phase 2 biotech developing small molecule therapies for NASH. Ark Global Acquisition (ARKIU) $300M $375M 0% +7% +7% Blank check company led by a former Groupon CEO and QIA fund manager targeting disruptive technology. Atlas Crest Investment II (ACII.U) $300M $375M 0% +7% +7% Second blank check company formed by Moelis and Company. CC Neuberger Holdings III (PRPC.U) $350M $488M 0% +7% +7% Third blank check company formed by CC Capital and Neuberger Berman. Thunder Bridge III (TBCPU) $360M $459M 0% +6% +6% Third blank check company led by Gary Simanson targeting the fintech industry. Angion Biomedica (ANGN) $80M $512M 7% +6% +6% Phase 3 biotech developing small molecule therapies for acute organ injuries. Jaws Mustang Acquisition (JWSM.U) $900M $1,125M 0% +6% +6% Third blank check company led by Starwood Capital founder Barry Sternlicht. Compute Health Acq. (CPUH.U) $750M $938M 0% +5% +5% Blank check company targeting the intersection of computation and healthcare. Music Acquisition (TMAC.U) $200M $250M 0% +5% +5% Blank check company targeting the music sector. Noble Rock Acquisition (NRACU) $210M $263M 0% +3% +5% Blank check company formed by Noble Rock Advisors targeting the software and tech-enabled services sectors. HH&L Acquisition (HHLA.U) $360M $450M 0% +5% +5% Blank check company targeting the healthcare sector in Asia. JOFF Fintech Acq. (JOFFU) $360M $450M 0% +4% +4% Blank check company targeting the financial services industry and FinTech. COVA Acquisition (COVAU) $261M $326M 0% +4% +4% Blank check company formed by Crescent Cove Advisors targeting tech businesses in Southeast Asia. Gaming & Hospitality Acq. (GHACU) $175M $227M 0% +4% +4% Blank check company formed by Affinity Gaming targeting the gaming and hospitality sectors. Ares Acquisition (AAC.U) $870M $1,088M 0% +4% +4% Blank check company formed by Ares Management targeting a sustainable business. Centricus Acquisition (CENHU) $300M $375M 0% +4% +4% UK-based blank check company led by former executives at Silversea Cruises and Deutsche Bank. Itiquira Acquisition (ITQRU) $200M $250M 0% +3% +4% Blank check company targeting growth sectors in Brazil. Thimble Point Acquisition (THMAU) $240M $300M 0% +4% +4% Blank check company targeting high-growth software and technology. Kernel Group (KRNLU) $265M $331M 0% +4% +3% Blank check company targeting technology infrastructure sectors. Quantum FinTech Acq. (QFTA.U) $175M $219M 0% +2% +2% Blank check company targeting businesses providing tech services to the financial sector. Astrea Acquisition (ASAXU) $150M $192M 0% +2% +2% Blank check company targeting the hospitality and financial services sectors. MDH Acquisition (MDH.U) $240M $300M 0% +2% +2% Blank check company formed by McLarty Diversified Holdings targeting businesses in the Heartland. Altimar Acquisition II (ATMRU) $300M $375M 0% n/a +0% Second blank check company formed by HPS Investment Partners. Evaxion Biotech (EVAX) $30M $214M -9% -1% -1% Danish Phase 1/2 biotech using AI to develop immuno-oncology therapies. Landos Biopharma (LABP) $100M $650M 0% -25% -31% Phase 2 biotech developing oral small molecule therapies for autoimmune diseases.
- Forums
- ASX - By Stock
- GMV
- GMVD - NASDAQ IPO
GMVD - NASDAQ IPO, page-1298
-
- There are more pages in this discussion • 634 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online